1. AngioLight Lands Strategic Partnership with Medical Technologies Innovation Asia, Names Gary Saxton President

    AngioLight Lands Strategic Partnership with Medical Technologies Innovation Asia, Names Gary Saxton President

    Interventional cardiology medical device company AngioLight has engaged in a strategic partnership with Medical Technologies Innovation Asia (MTIA), Hong Kong, under which MTIA will complete safety, animal and clinical studies of AngioLight’s light-based diagnostic catheter in exchange for equity in AngioLight. Developed to support the eventual commercialization of AngioLight’s catheter first in China and then worldwide, the partnership will be managed by AngioLight’s newly appointed president, Gary Saxton, who previously served as business development consultant to the company.

    AngioLight’s novel light-based diagnostic catheter provides cardiologists real-time vessel diameter and area measurements as an adjunct to coronary ...

    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources, Velocimetry
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Quotes

    1. AngioLight's technology has the potential to fill a significant unmet clinical need in interventional cardiology by reducing the potential for complications following stenting.
      By Gary Saxton
    2. Our oversubscribed C round is a testament to AngioLight's technology, our leadership and our new strategy.
      By Steven Slavsky